RT Journal Article
SR Electronic
T1 Ideology, policy decision-making and environmental impact in the face of the Coronavirus pandemic in the US
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.01.21262952
DO 10.1101/2021.09.01.21262952
A1 Prieto-Rodríguez, Juan
A1 Salas, Rafael
A1 Noonan, Douglas
A1 Cabeza-Martinez, Francisco
A1 Ramos-Gutiérrez, Javier
YR 2021
UL http://medrxiv.org/content/early/2021/09/05/2021.09.01.21262952.abstract
AB Covid-19 pandemic was a challenge for the health systems of many countries. It altered people’s way of life and shocked the world economy. In the United States, political ideology has clashed with the fight against the pandemic. President Trump’s denial prevailed despite the warnings from the WHO and scientists who alerted of the seriousness of the situation. Despite this, some state governments did not remain passive in the absence of federal government measures, and passed laws restricting mobility (lockdowns). Consequently, the political polarity was accentuated. On the one hand, the defenders of more severe public health measures and, on the other, the advocates of individual rights and freedom above any other consideration. In this study, we analyze whether political partisanship and the political ideology has influenced the way Covid-19 was handled at the outbreak. Specifically, we analyze by using a Diff-in-Diff model, whether the ideology of each state, measure at three levels, affected the decrease in the NO2 levels observed after the pandemic outbreak in the US. We distinguish three alternative post-Covid periods and results show that the State ideology has a robust negative impact on the NO2 levels. There is an important difference between Democratic and Republican states, not just in the scope and following-up of the mobility and activity restrictions, but also in the speed they implemented them.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the grants #ECO2017-86402-C2-1-R and PID2019-104619RB-C42 from the Spanish Ministry of Economy, Industry and Competitiveness.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and Stata code are available under request.